Extracellular TG2: emerging functions and regulation.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMC 3228878)

Published in FEBS J on November 21, 2011

Authors

Alexey M Belkin1

Author Affiliations

1: Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. abelkin@som.umaryland.edu

Articles citing this

Transglutaminase regulation of cell function. Physiol Rev (2014) 1.28

Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol (2012) 1.27

Endothelial sirtuin 1 deficiency perpetrates nephrosclerosis through downregulation of matrix metalloproteinase-14: relevance to fibrosis of vascular senescence. J Am Soc Nephrol (2013) 1.01

Role of transglutaminase 2 in celiac disease pathogenesis. Semin Immunopathol (2012) 0.98

Exercise, vascular stiffness, and tissue transglutaminase. J Am Heart Assoc (2014) 0.93

Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence. PLoS One (2013) 0.90

Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix. J Biol Chem (2012) 0.87

Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation. J Neurosci (2012) 0.86

Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma. J Pathol (2013) 0.83

Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis. J Am Soc Nephrol (2013) 0.83

Transglutaminase 2-mediated serotonylation in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2013) 0.82

Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans. Front Immunol (2014) 0.82

Syndecan 4 regulation of PDK1-dependent Akt activation. Cell Signal (2012) 0.81

Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death. Cell Death Dis (2016) 0.80

Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation. J Vasc Res (2015) 0.79

Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis. Curr Diab Rep (2016) 0.79

Molecular Cues Guiding Matrix Stiffness in Liver Fibrosis. Biomed Res Int (2016) 0.78

Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family. ScientificWorldJournal (2014) 0.78

Transglutaminase 2--a novel inhibitor of adipogenesis. Cell Death Dis (2015) 0.77

Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression. Clin Cancer Res (2015) 0.77

The Reduction-insensitive Bonds of the MUC2 Mucin Are Isopeptide Bonds. J Biol Chem (2016) 0.77

Syndecan 4 signaling is required for exercise-induced cardiac hypertrophy. Mol Med (2016) 0.77

Expression of Functional Recombinant Human Tissue Transglutaminase (TG2) Using the Bac-to-Bac Baculovirus Expression System. Adv Pharm Bull (2016) 0.77

Lysyl oxidases in the trabecular meshwork. J Glaucoma (2014) 0.77

Transglutaminase 2 Modulation of NF-κB Signaling in Astrocytes is Independent of its Ability to Mediate Astrocytic Viability in Ischemic Injury. Brain Res (2017) 0.77

Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation. Cancer Res (2016) 0.76

Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis. Amino Acids (2016) 0.76

Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway. Oncotarget (2016) 0.75

Transglutaminase inhibition: A therapy to protect cells from death in neurodegeneration? World J Biol Chem (2012) 0.75

Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter. PLoS One (2014) 0.75

Transglutaminase 2 expression and its prognostic significance in clear cell renal cell carcinoma. J Pathol Transl Med (2015) 0.75

Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney. Kidney Int (2016) 0.75

Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination. Sci Rep (2017) 0.75

How old are your arteries? Exercise-mediated protection from age-associated vascular stiffness. J Am Heart Assoc (2014) 0.75

Expression of Transglutaminase in Foreskin of Children with Balanitis Xerotica Obliterans. Int J Mol Sci (2016) 0.75

Inhibition or ablation of transglutaminase 2 impairs astrocyte migration. Biochem Biophys Res Commun (2016) 0.75

Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2. J Biol Chem (2016) 0.75

Reactive Oxygen Species Affect Transglutaminase Activity and Regulate Hematopoiesis in a Crustacean. J Biol Chem (2016) 0.75

PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation. J Leukoc Biol (2016) 0.75

Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia. Neuroreport (2017) 0.75

Articles cited by this

Matrix metalloproteinases: regulators of the tumor microenvironment. Cell (2010) 12.90

Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev (1999) 8.36

Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol (2003) 6.05

Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol (2009) 3.52

LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev (2008) 3.46

Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol (2008) 3.17

The thrombospondins. Int J Biochem Cell Biol (2004) 3.01

Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol (2000) 2.86

Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol (2007) 2.53

Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev (2009) 2.17

Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci U S A (2002) 2.15

GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci U S A (2006) 2.08

The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr Opin Cell Biol (2008) 1.89

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res (2006) 1.82

Integrin regulation of growth factor receptors. Nat Cell Biol (2002) 1.80

Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res (2000) 1.74

Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene (2006) 1.72

Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem (2001) 1.69

Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One (2008) 1.67

Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood (2001) 1.66

The role of tissue transglutaminase in cell-matrix interactions. Front Biosci (2006) 1.65

Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition. J Cell Sci (2001) 1.61

Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem (1991) 1.60

Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. J Cell Physiol (1991) 1.47

Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr Biol (2003) 1.43

p190RhoGAP is the convergence point of adhesion signals from alpha 5 beta 1 integrin and syndecan-4. J Cell Biol (2008) 1.41

Redox regulation of transglutaminase 2 activity. J Biol Chem (2010) 1.38

Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol (1993) 1.35

Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. J Biol Chem (1999) 1.35

Site-directed perturbation of protein kinase C- integrin interaction blocks carcinoma cell chemotaxis. Mol Cell Biol (2002) 1.35

Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res (2010) 1.30

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. Cancer Res (2007) 1.29

Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. Proc Natl Acad Sci U S A (1993) 1.29

Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem (2002) 1.28

Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res (2009) 1.27

Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes. PLoS One (2011) 1.22

Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem (2008) 1.21

Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell (2006) 1.21

Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry (2001) 1.20

Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide. J Biol Chem (2009) 1.20

Tissue transglutaminase (TG2)--a wound response enzyme. Front Biosci (2006) 1.19

Proteolysis of cell-surface tissue transglutaminase by matrix metalloproteinase-2 contributes to the adhesive defect and matrix abnormalities in thrombospondin-2-null fibroblasts and mice. Am J Pathol (2005) 1.17

Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J Cell Biol (1992) 1.17

Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2. J Biol Chem (2009) 1.17

Complexation of fibronectin with tissue transglutaminase. Biochemistry (1989) 1.16

Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res (2008) 1.16

Integrins enhance platelet-derived growth factor (PDGF)-dependent responses by altering the signal relay enzymes that are recruited to the PDGF beta receptor. J Biol Chem (1999) 1.16

Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol (2009) 1.13

Single proteins might have dual but related functions in intracellular and extracellular microenvironments. Nat Rev Mol Cell Biol (2009) 1.12

Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci (2004) 1.10

Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp Cell Res (2006) 1.06

Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett (2008) 1.06

Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry (1994) 1.05

Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells. Stem Cells (2007) 1.05

RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling. J Biol Chem (2010) 1.05

Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional protein. FEBS J (2011) 1.03

Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase. J Biol Chem (2009) 1.03

Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1. J Cell Sci (2007) 0.98

Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp Cell Res (2010) 0.96

Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin. Exp Cell Res (1999) 0.96

Cell-surface-associated tissue transglutaminase is a target of MMP-2 proteolysis. Biochemistry (2004) 0.94

Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells. Biochem J (2010) 0.94

New insights into the functions and localization of nuclear transglutaminase 2. FEBS J (2011) 0.92

Lamellipodium extension and membrane ruffling require different SNARE-mediated trafficking pathways. BMC Cell Biol (2010) 0.89

Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. FEBS J (2011) 0.88

Novel interactions of TG2 with heparan sulfate proteoglycans: reflection on physiological implications. Amino Acids (2008) 0.87

Significance of the syndecan-4-transglutaminase-2 interaction. ScientificWorldJournal (2010) 0.84

Lipids associated with tissue transglutaminase. Biochim Biophys Acta (1987) 0.84

Over-expression of integrin beta3 can partially overcome the defect of integrin beta3 signaling in transglutaminase 2 null macrophages. Immunol Lett (2009) 0.84

The interaction of angiocidin with tissue transglutaminase. Exp Mol Pathol (2009) 0.84

Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers. J Biol Chem (1990) 0.82

Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration? Brain Pathol (2010) 0.81